Breast Cancer Research Info
Breast cancer is considered as a fatal illness and it is known to be the number one cause of cancer death among women. According to American cancer society, about 1.3 million new breast cancer instances are identified every year which includes 465,000 deaths. In order to productively tackle this disturbing disease, we must push revolutionary scientists to research cancer at its most basic level. In other words, breast cancer research work should be conducted at its molecular stage. Also, besides the governments, private organizations should provide flexible funding to scientists who will be conducting breast cancer research work.
Appropriate funding of breast cancer investigation projects; can not only result to improved prevention methods but it can also assist towards earlier detection techniques and new anticancer medication and treatments.
Recently, researchers who are working towards breast cancer research project, have developed and successfully tested a breast cancer vaccine which is probably to cure women with treatment – resistant HER2 – positive breast cancer and thus be able to prevent cancer remission. Breast cancer scientists look forward to use HER2 DNA vaccines for cancer-free women, in order to prevent initial development of such tumours. Today therapies such as trastuzumab and lapatimib are used in treating breast cancer patients. But, it was recently noticed that a large group of patients build up a resistance in trastuzumab and lapatimib. HER2 receptors are known to endorse a specifically destructive type of cancer that affects about thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body’s own cells. It offers a cancer combating gene into cells, which then produce immune system proteins as well as cancer ? fighting cells.
According to the primary researcher Wei – Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is made by utilizing so – called naked DNA from genes that produces the HER2 receptor. This DNA is combined with an immune stimulant. The process involved in the making of the vaccine, is called as electro oration.
In this process, pulses of electricity were used in order to inject the vaccine into the leg muscles in rats. The genes moved towards the cells, which then produced HER2 receptors that directed to launching of antibodies and immune cells called Killer T cells.